These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16446540)

  • 1. Effect of smoking status on outcome after acute ischemic stroke.
    Ovbiagele B; Weir CJ; Saver JL; Muir KW; Lees KR;
    Cerebrovasc Dis; 2006; 21(4):260-5. PubMed ID: 16446540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcome after atherosclerotic stroke in male smoker.
    Bang OY; Park HY; Lee PH; Kim GM; Chung CS; Lee KH
    J Neurol Sci; 2007 Sep; 260(1-2):43-8. PubMed ID: 17477936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
    Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
    J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The smoking-thrombolysis paradox and acute ischemic stroke.
    Ovbiagele B; Saver JL
    Neurology; 2005 Jul; 65(2):293-5. PubMed ID: 16043802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level.
    Ovbiagele B; Saver JL
    Cerebrovasc Dis; 2010; 29(1):50-6. PubMed ID: 19893312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.
    Muir KW; Lees KR; Ford I; Davis S;
    Lancet; 2004 Feb; 363(9407):439-45. PubMed ID: 14962524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of differences in case mix on the better outcome of smokers after intravenous thrombolysis for acute cerebral ischemia.
    Moulin S; Padjen-Bogosavljevic V; Marichal A; Cordonnier C; Jovanovic DR; Gautier S; Hénon H; Beslac-Bumbasirevic L; Bordet R; Leys D
    Eur Neurol; 2012; 67(3):178-83. PubMed ID: 22286144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of statins on acute and long-term outcome after ischemic stroke in the elderly.
    Hjalmarsson C; Bokemark L; Manhem K; Mehlig K; Andersson B
    Am J Geriatr Pharmacother; 2012 Oct; 10(5):313-22. PubMed ID: 23063287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged QTc as a predictor of mortality in acute ischemic stroke.
    Stead LG; Gilmore RM; Bellolio MF; Vaidyanathan L; Weaver AL; Decker WW; Brown RD
    J Stroke Cerebrovasc Dis; 2009; 18(6):469-74. PubMed ID: 19900651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial.
    Aslanyan S; Fazekas F; Weir CJ; Horner S; Lees KR;
    Stroke; 2003 Oct; 34(10):2420-5. PubMed ID: 14500934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undernutrition as a predictor of poor clinical outcomes in acute ischemic stroke patients.
    Yoo SH; Kim JS; Kwon SU; Yun SC; Koh JY; Kang DW
    Arch Neurol; 2008 Jan; 65(1):39-43. PubMed ID: 18195138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality.
    Elkind MS; Flint AC; Sciacca RR; Sacco RL
    Neurology; 2005 Jul; 65(2):253-8. PubMed ID: 16043795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in daily practice.
    Dirks M; Niessen LW; van Wijngaarden J; Koudstaal PJ; Franke CL; van Oostenbrugge RJ; Dippel DW;
    Int J Stroke; 2012 Jun; 7(4):289-92. PubMed ID: 22168317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis.
    Bang OY; Saver JL; Liebeskind DS; Starkman S; Villablanca P; Salamon N; Buck B; Ali L; Restrepo L; Vinuela F; Duckwiler G; Jahan R; Razinia T; Ovbiagele B
    Neurology; 2007 Mar; 68(10):737-42. PubMed ID: 17182976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M; Diener HC; Kaste M; Mau J
    Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
    Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
    N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria and clinical outcomes after ischemic stroke.
    Kumai Y; Kamouchi M; Hata J; Ago T; Kitayama J; Nakane H; Sugimori H; Kitazono T;
    Neurology; 2012 Jun; 78(24):1909-15. PubMed ID: 22592359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.